86720-98-1

Upstream product

• 7206-70-4 4-amino-5-chloro-2-methoxybenzoic acid 

Downstream Products

• 1346763-34-5 trans-4-[[3-(2-chloro-4-formyl-5-methoxyphenoxy)propyl](methyl)amino]cyclohexyl hydroxy(di-2-thienyl)acetate 
• 1346763-32-3 trans-4-[{3-[2-chloro-4-(hydroxymethyl)-5-methoxyphenoxy]propyl}(methyl)amino]cyclohexyl hydroxy(di-2-thienyl)acetate 
• 1346764-93-9 [4-(4-bromobutoxy)-5-chloro-2-methoxyphenyl]methanol 
• 1346763-29-8 [4-(3-bromopropoxy)-5-chloro-2-methoxyphenyl]methanol 
• 1346763-27-6 2-chloro-4-(hydroxymethyl)-5-methoxyphenol 
• 28478-47-9 methyl 5-chloro-4-hydroxy-2-methoxybenzoate 

Relevant academic research and scientific papers

NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES

The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.

New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities

The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.